H-alpha-Me-D-Nva-OH

H-alpha-Me-D-Nva-OH is a chiral amino acid derivative featuring a D-configured amino acid backbone with an alpha-methyl substituent (H-alpha-Me) and a norvaline (Nva) side chain, terminating as a free carboxylic acid (OH). The molecule contains a stereogenic center at the alpha carbon, enabling stereochemically defined incorporation into peptide-like structures and chiral synthetic sequences. The unprotected primary amino functionality and carboxylic acid provide direct handles for peptide coupling chemistry, salt formation, and subsequent functional group transformation. The combination of a D-configuration with alpha-methyl substitution can influence conformational preferences in downstream peptides and peptidomimetics, making it a useful chiral amino acid intermediate for structure-defined synthesis.

1. Peptide Synthesis

H-alpha-Me-D-Nva-OH is applied in peptide building and fragment coupling workflows where a D-configured, alpha-methylated amino acid residue is needed to control stereochemistry at the coupling site. The side-chain length of the norvaline unit supports hydrophobic interactions in peptide sequences, while the free carboxyl group and amino functionality can be converted into activated species or protected forms to participate in amide bond formation. Alpha-methyl substitution can modulate backbone conformational behavior, which is relevant for generating stereochemically constrained peptide analogs using standard peptide coupling strategies. Downstream peptide products can be assembled as research-grade intermediates for biochemical assays, peptide library construction, and mapping of residue-level structure effects.

2. Unnatural Amino Acid Incorporation

H-alpha-Me-D-Nva-OH serves as a chiral amino acid intermediate for unnatural amino acid incorporation into peptides and peptidomimetics, particularly when D-configuration and alpha-methyl substitution are required for defined stereochemical outcomes. The D-stereocenter and alpha-methyl group create a distinct steric and stereoelectronic environment compared with non-methylated analogs, which can be leveraged to tune local secondary structure propensity and protease resistance in peptide-like constructs. The norvaline side chain provides a hydrophobic handle that can be maintained or further derivatized after incorporation. The resulting modified amino acid residue can be used to generate structure-defined analog series for synthetic methodology studies and residue-specific biochemical investigations.

3. Side-Chain Functionalization

H-alpha-Me-D-Nva-OH is suitable for side-chain and backbone derivatization routes that begin from a defined amino acid skeleton bearing a norvaline chain and a stereogenic alpha carbon. The free amino and carboxylic acid groups enable orthogonal protection and selective activation, allowing downstream transformation into N-protected derivatives for controlled chemistry while preserving the stereocenter. The alpha-methyl substitution can affect reactivity patterns during derivatization and can be retained to maintain the intended conformational bias in final products. Functionalized derivatives generated from this starting material can feed into medicinal chemistry intermediate preparation, peptidomimetic scaffold diversification, and chiral building block synthesis for fragment-based molecular design.

4. Chiral Synthesis Intermediate

H-alpha-Me-D-Nva-OH functions as a chiral synthetic intermediate for process chemistry and fine chemical synthesis where stereochemical fidelity at the alpha carbon is required. The D-configuration and alpha-methyl substitution provide a defined stereochemical motif that can be carried through multi-step sequences to produce downstream amino acid esters, protected amino acids, or activated carboxylic acid derivatives. The norvaline side chain length supports conversion into higher-value intermediates used in peptide coupling chemistry and chiral scaffold elaboration. This makes H-alpha-Me-D-Nva-OH applicable to manufacturing-oriented planning for stereochemically consistent amino acid derivative families and for producing defined chiral intermediates for industrial chemical production.

5. Analytical Research Standards

H-alpha-Me-D-Nva-OH can be employed in analytical method development and stereochemical characterization workflows for amino acid derivatives and peptide hydrolysates. The presence of a defined D-configuration, alpha-methyl substitution, and free carboxylic acid enables chromatographic differentiation and can support calibration or identification of stereochemically related compounds. The amino acid framework allows conversion into derivatization-ready forms for LC-MS or chiral HPLC workflows, aiding monitoring of synthetic steps and impurity profiling. The resulting analytical reference material supports quality control of protected amino acid synthesis, peptide building block preparation, and downstream verification of stereochemical integrity in peptide science.

1. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review

2. Implications of ligand-receptor binding kinetics on GLP-1R signalling

3. Spatiotemporal delivery of nanoformulated liraglutide for cardiac regeneration after myocardial infarction

4. Application of human liver organoids as a patient-derived primary model for HBV infection and related hepatocellular carcinoma

5. Cationic cell-penetrating peptides are potent furin inhibitors